Background illustration for clinical trials search

Paid Clinical Trials Missouri

Discover 1,809 paid clinical trials in Missouri. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase 3, Recruiting

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

for
Embryonal Rhabdomyosarcoma,
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT05304585

Phase 3, Recruiting

A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors

for
Low-grade Glioma, Advanced Solid Tumor
Location: Boston MA, Quebec, New York NY, Montreal,
Sponsor: Day One Biopharmaceuticals, Inc.

Sex: All

Age: 0 - 25

Code: NCT04775485

Phase 2, Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

for
Heart Failure and Impaired Kidney Function
Location: Sydney, Boston MA, Providence RI, The Bronx NY,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06307652

Phase 3, Recruiting

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

for
Ovarian Carcinoma
Location: Portland ME, Scarborough ME, Boston MA, Providence RI,
Sponsor: NRG Oncology

Sex: Female

Age: 35 - 50

Code: NCT04251052

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Pompe Disease Registry Protocol

for
Glycogen Storage Disease Type II, Pompe Disease
Location: Moncton, Portland ME, Boston MA, Springfield MA,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00231400

Recruiting

A Study of ASP3082 in Adults With Advanced Solid Tumors

for
Solid Tumor
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Astellas Pharma Inc

Sex: All

Age: 18+

Code: NCT05382559

Phase 1, Recruiting

Low Field Magnetic Resonance Imaging Assessment With Outpatients

for
Conditions Requiring a Brain Magnetic Resonance Imaging, Head Computerized Tomography, or Head Ultrasound,
Location: Kansas City MO
Sponsor: Children's Mercy Hospital Kansas City

Sex: All

Age: 0 - 22

Code: NCT05582785

Recruiting

Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)

for
Delirium
Location: Boston MA, The Bronx NY, New York NY, Baltimore MD,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 60+

Code: NCT06192615

Phase 3, Recruiting

Evaluating Therapeutic Electrical Stimulation to Improve Nerve Healing After Surgical Repair of Digital Nerve Injuries

for
Digital Nerve Injury, Nerve Injury, Nerve Reconstruction,
Location: Columbus OH, Indianapolis IN, St Louis MO, Columbia MO,
Sponsor: Checkpoint Surgical Inc.

Sex: All

Age: 18 - 70+

Code: NCT06867185

Recruiting

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

for
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Location: New York NY, Philadelphia PA, Hershey PA, Danville PA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT05519475

Phase 2, Recruiting

Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy

for
Lung Cancer
Location: New Brunswick NJ, Rochester NY, Columbia MO
Sponsor: Bo Lu

Sex: All

Age: 18+

Code: NCT06410300

Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Mira Road, Halifax, Bangor ME, Fall River MA, Boston MA,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase 3, Recruiting

A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects

for
Neuroblastoma, Neuroectodermal Tumors, Neoplasms
Location: Boston MA, New Hyde Park NY, New York NY,
Sponsor: Jubilant DraxImage Inc.

Sex: All

Age: 1+

Code: NCT03561259

Phase 2, Recruiting

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

for
Multiple Myeloma
Location: Moncton, Boston MA, Providence RI, Lake Success NY,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06152575

Phase 3, Recruiting

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

for
Colitis, Ulcerative
Location: Boston MA, Worcester MA, New York NY, Toronto,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 2 - 17

Code: NCT05076175

Phase 2, Phase 3, Recruiting

Fabry Disease Registry & Pregnancy Sub-registry

for
Fabry Disease
Location: St. John's, Halifax, Portland ME, Boston MA,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00196742

Recruiting

SLV-154 Treatment of Advanced Cancers

for
Advanced Cancer, Advanced Solid Tumor, Metastatic Cancer
Location: New York NY, East Brunswick NJ, Philadelphia PA,
Sponsor: Solve Therapeutics

Sex: All

Age: 12+

Code: NCT06771219

Phase 1, Recruiting

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Brunswick ME, Portland ME, Scarborough ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06317649

Phase 2, Recruiting

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

for
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT04322318

Phase 2, Recruiting

Popular cities in Missouri

With its expansive healthcare network and renowned medical research institutions, Missouri is a central hub for a diverse range of clinical trials. Leading organizations such as Washington University School of Medicine in St. Louis, the University of Missouri Health Care, and St. Louis University are at the forefront of groundbreaking studies. These institutions drive innovation in medical research and offer unique opportunities for participants to engage in cutting-edge clinical trials, contributing to advancements in healthcare both locally and nationwide.

Why choose Missouri for clinical trials?

Missouri has a diverse population which ensures a wide variety of participants can take part in clinical trials, enhancing the accuracy, applicability, and validity of clinical research findings. The state is also home to a thriving research environment, with a strong emphasis on medical innovation and cutting-edge studies led by world-class institutions.

By choosing to participate in a clinical trial in Missouri, individuals contribute to critical advancements in medical research while benefiting from a well-established and supportive clinical research infrastructure.

Common conditions studied in Missouri

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Missouri